Caudal Epidural Prolotherapy Versus Steroids in Failed Back Surgery Syndrome
The Efficacy of Ultrasound and Fluoroscopy Guided Caudal Epidural Prolotherapy Versus Steroids for Chronic Pain Management in Failed Back Surgery Syndrome
1 other identifier
interventional
90
1 country
1
Brief Summary
This study will be held on patients with failed back surgery syndrome, the investigators are comparing prolotherapy and steroids injections in caudal epidural space to relieve the pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2022
CompletedFirst Submitted
Initial submission to the registry
September 14, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedNovember 29, 2024
November 1, 2024
1.6 years
September 14, 2022
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessing in both groups the Visual analogue scale from 0-10 where 0 indicates no pain and 10 indicates maximum pain
A decrease in VAS score after 2 weeks by 50 percent or more from pre-injection level is considered successful
2 weeks
Secondary Outcomes (4)
the level reached by the injectate
at time of injection
assessing the patient satisfaction by a the short assessment of patient satisfaction score (SAPS) from 0 to 28 where 0 is so dissatisfied and 28 means very satisfied
6 months
further change in visual analogue scale
2 weeks till 6 months
recording the number of patients who encountered any complications and treating them accordingly
6 months
Study Arms (2)
Steroid group (Group S)
ACTIVE COMPARATORThis group will receive ultrasound and fluoroscopy-guided caudal epidural steroid injection
Prolotherapy group (Group P)
EXPERIMENTALThis group will receive ultrasound and fluoroscopy-guided caudal epidural prolotherapy injection
Interventions
a type of steroids injected in epidural space
Eligibility Criteria
You may qualify if:
- patients diagnosed with failed back surgery syndrome, having chronic pain for more than 3 months by a detailed assessment including medical history and examination
- patients having positive radiological (MRI) findings of spinal nerve roots being irritated or compressed after having surgery for one of many conditions including: lumbar disc herniation, spinal canal stenosis, osteophytes, spodylolithesis or foramen stenosis
- patients whom another surgery is not indicated
You may not qualify if:
- patient refusal
- pregnancy
- systemic infection or infection at the site of injection
- patients on anticoagulation
- immunocompromised patients as uncontrolled diabetes, osteoporosis as a contraindication for steroid injection
- patients with renal impairment or on dialysis
- acute disc prolapse as it requires immediate surgery
- opioid use
- concurrent significant depressive illness, inflammatory of joint disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmed S. Shehab
Alexandria, Egypt
Related Publications (1)
Maniquis-Smigel L, Reeves KD, Rosen HJ, Lyftogt J, Graham-Coleman C, Cheng AL, Rabago D. Analgesic Effect and Potential Cumulative Benefit from Caudal Epidural D5W in Consecutive Participants with Chronic Low-Back and Buttock/Leg Pain. J Altern Complement Med. 2018 Dec;24(12):1189-1196. doi: 10.1089/acm.2018.0085. Epub 2018 Jun 8.
PMID: 29883193RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed S shehab
Alexandria University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) double blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer in Anaesthesia and Surgical ICU department
Study Record Dates
First Submitted
September 14, 2022
First Posted
September 21, 2022
Study Start
April 20, 2022
Primary Completion
November 30, 2023
Study Completion
June 30, 2024
Last Updated
November 29, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- After study ends upon request
- Access Criteria
- Accessible through the web site
there is a plan to make individual participant data (IPD) collected in this study, including data dictionaries, available to other researchers